Your browser doesn't support javascript.
loading
B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS.
Wang, Sophia S; Vajdic, Claire M; Linet, Martha S; Slager, Susan L; Voutsinas, Jenna; Nieters, Alexandra; Casabonne, Delphine; Cerhan, James R; Cozen, Wendy; Alarcón, Graciela; Martínez-Maza, Otoniel; Brown, Elizabeth E; Bracci, Paige M; Turner, Jennifer; Hjalgrim, Henrik; Bhatti, Parveen; Zhang, Yawei; Birmann, Brenda M; Flowers, Christopher R; Paltiel, Ora; Holly, Elizabeth A; Kane, Eleanor; Weisenburger, Dennis D; Maynadié, Marc; Cocco, Pierluigi; Foretova, Lenka; Breen, Elizabeth Crabb; Lan, Qing; Brooks-Wilson, Angela; De Roos, Anneclaire J; Smith, Martyn T; Roman, Eve; Boffetta, Paolo; Kricker, Anne; Zheng, Tongzhang; Skibola, Christine F; Clavel, Jacqueline; Monnereau, Alain; Chanock, Stephen J; Rothman, Nathaniel; Benavente, Yolanda; Hartge, Patricia; Smedby, Karin E.
Afiliación
  • Wang SS; Division of Health Analytics, Department of Computational and Quantitative Medicine, Beckman Research Institute of the City of Hope, Monrovia, California.
  • Vajdic CM; Centre for Big Data Research in Health, The University of New South Wales, Sydney, New South Wales, Australia.
  • Linet MS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland.
  • Slager SL; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
  • Voutsinas J; Division of Health Analytics, Department of Computational and Quantitative Medicine, Beckman Research Institute of the City of Hope, Monrovia, California.
  • Nieters A; The Center for Chronic Immunodeficiency, University Medical Center Freiburg, Freiburg, Germany.
  • Casabonne D; Unit of Infections and Cancer, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program - Epibell, IDIBELL, Institut Català d' Oncologia/IDIBELL, Barcelona, Spain.
  • Cerhan JR; The Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Cozen W; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
  • Alarcón G; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, California.
  • Martínez-Maza O; Division of Clinical Immunology and Rheumatology, Department of Medicine, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama.
  • Brown EE; Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.
  • Bracci PM; Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.
  • Turner J; Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, California.
  • Hjalgrim H; Department of Pathology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama.
  • Bhatti P; O'Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, Alabama.
  • Zhang Y; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California.
  • Birmann BM; Department of Histopathology, Douglass Hanly Moir Pathology, Sydney, New South Wales, Australia.
  • Flowers CR; Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.
  • Paltiel O; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
  • Holly EA; British Columbia Cancer Research Center, Vancouver, British Columbia, Canada.
  • Kane E; Department of Cancer Prevention and Control at the National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Weisenburger DD; Channing Division of Network Medicine, Department of Medicine Research, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Maynadié M; Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Cocco P; Department of Hematology, The Hebrew University-Hadassah Braun School of Public Health and Community Medicine, Hadassah University Medical Center, Jerusalem, Israel.
  • Foretova L; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California.
  • Breen EC; Department of Health Sciences, University of York, York, United Kingdom.
  • Lan Q; Department of Pathology, City of Hope, Duarte, California.
  • Brooks-Wilson A; Registry of Hematological Malignancies of Cote d'Or, INSERM U1231, Burgundy University and University Hospital, Dijon, France (Maynadie).
  • De Roos AJ; Occupational Health Section, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Smith MT; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Roman E; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.
  • Boffetta P; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland.
  • Kricker A; Department of Biomedical Physiology and Kinesiology, Faculty of Science, Simon Fraser University, Vancouver, British Columbia, Canada.
  • Zheng T; Department of Environmental and Occupational Health, Dornsife School of Public Health, Drexel University, Philadelphia, Pennsylvania.
  • Skibola CF; Division of Environmental Health Sciences, School of Public Health, University of California, Berkeley, Berkeley, California.
  • Clavel J; Department of Health Sciences, University of York, York, United Kingdom.
  • Monnereau A; Stony Brook Cancer Center, Stony Brook University, Stony Brook, New York.
  • Chanock SJ; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Rothman N; Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Benavente Y; Department of Epidemiology, School of Public Health, Brown University, Providence, Rhode Island.
  • Hartge P; Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Smedby KE; Centre of Research in Epidemiology and Statistics (CRESS), UMR1153, INSERM, Université de Paris, Paris, France.
Cancer Epidemiol Biomarkers Prev ; 31(5): 1103-1110, 2022 05 04.
Article en En | MEDLINE | ID: mdl-35244686
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Linfoma Folicular / Linfoma de Células B Grandes Difuso Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Asunto de la revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Linfoma Folicular / Linfoma de Células B Grandes Difuso Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Asunto de la revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos